Dihydrolipoyl Transacetylase (DLAT) Peptide
DLAT
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all DLAT products
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- WTPSSGATPR NRLLLQLLGS PGRRYYSLPP HQKVPLPSLS PTMQAGTIAR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DLAT antibody,
Alternative Names: DLAT control peptide, DLAT antibody Blocking Peptide, Anti-DLAT Blocking Peptide, Dihydrolipoamide S-Acetyltransferase Blocking Peptide, E2 Component Of Pyruvate Dehydrogenase Complex Blocking Peptide, DLTA Blocking Peptide, PDC-E2 Blocking Peptide, PDCE2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
- Background
- DLAT is dihydrolipoamide acetyltransferase, the E2 subunit of the mammalian pyruvate dehydrogenase complex of the inner mitochondrial membrane. Patients with primary biliary cirrhosis show autoantibodies to DLAT.
- Molecular Weight
- 71 kDa
-
You are here:
